Physician profile
Winston Lee
NPI 1396709143
$1,859.69
in general payments reported to CMS, 2019-2025
9 companies · $29.57 in 2025
The $29.57 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2020: $285 · 2021: $396 · 2022: $548 · 2023: $120 · 2024: $274 · 2025: $29.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $422.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $745.11 | 2020-2024 | Lokelma |
| Vifor Pharma, INC. | $298.36 | 2022-2024 | Veltassa, Korsuva |
| Fresenius USA Marketing, INC. | $297.85 | 2019-2024 | Velphoro |
| Amgen INC. | $281.91 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $116.87 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $44.39 | 2020 | |
| Ardelyx, INC. | $29.57 | 2025 | Ibsrela |
| Takeda Pharmaceuticals U.S.A., INC. | $24.02 | 2020 | |
| Calliditas Therapeutics US INC. | $21.61 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Winston Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.